223 related articles for article (PubMed ID: 21521932)
1. Pitavastatin increases ABCA1 expression by dual mechanisms: SREBP2-driven transcriptional activation and PPARα-dependent protein stabilization but without activating LXR in rat hepatoma McARH7777 cells.
Maejima T; Sugano T; Yamazaki H; Yoshinaka Y; Doi T; Tanabe S; Nishimaki-Mogami T
J Pharmacol Sci; 2011; 116(1):107-15. PubMed ID: 21521932
[TBL] [Abstract][Full Text] [Related]
2. Sterol regulatory element-binding protein-2- and liver X receptor-driven dual promoter regulation of hepatic ABC transporter A1 gene expression: mechanism underlying the unique response to cellular cholesterol status.
Tamehiro N; Shigemoto-Mogami Y; Kakeya T; Okuhira K; Suzuki K; Sato R; Nagao T; Nishimaki-Mogami T
J Biol Chem; 2007 Jul; 282(29):21090-9. PubMed ID: 17526932
[TBL] [Abstract][Full Text] [Related]
3. Regulation mechanism of ABCA1 expression by statins in hepatocytes.
Kobayashi M; Gouda K; Chisaki I; Ochiai M; Itagaki S; Iseki K
Eur J Pharmacol; 2011 Jul; 662(1-3):9-14. PubMed ID: 21554872
[TBL] [Abstract][Full Text] [Related]
4. Regulation of multidrug resistance protein 2 (MRP2, ABCC2) expression by statins: involvement of SREBP-mediated gene regulation.
Kobayashi M; Gouda K; Chisaki I; Asada K; Ogura J; Takahashi N; Konishi T; Koshida Y; Sasaki S; Yamaguchi H; Iseki K
Int J Pharm; 2013 Aug; 452(1-2):36-41. PubMed ID: 23612356
[TBL] [Abstract][Full Text] [Related]
5. Pitavastatin effect on ATP binding cassette A1-mediated lipid efflux from macrophages: evidence for liver X receptor (LXR)-dependent and LXR-independent mechanisms of activation by cAMP.
Zanotti I; Potì F; Favari E; Steffensen KR; Gustafsson JA; Bernini F
J Pharmacol Exp Ther; 2006 Apr; 317(1):395-401. PubMed ID: 16415093
[TBL] [Abstract][Full Text] [Related]
6. Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. II. LXRs suppress lipid degradation gene promoters through inhibition of PPAR signaling.
Ide T; Shimano H; Yoshikawa T; Yahagi N; Amemiya-Kudo M; Matsuzaka T; Nakakuki M; Yatoh S; Iizuka Y; Tomita S; Ohashi K; Takahashi A; Sone H; Gotoda T; Osuga J; Ishibashi S; Yamada N
Mol Endocrinol; 2003 Jul; 17(7):1255-67. PubMed ID: 12730332
[TBL] [Abstract][Full Text] [Related]
7. Statin-induced decrease in ATP-binding cassette transporter A1 expression via microRNA33 induction may counteract cholesterol efflux to high-density lipoprotein.
Niesor EJ; Schwartz GG; Perez A; Stauffer A; Durrwell A; Bucklar-Suchankova G; Benghozi R; Abt M; Kallend D
Cardiovasc Drugs Ther; 2015 Feb; 29(1):7-14. PubMed ID: 25749868
[TBL] [Abstract][Full Text] [Related]
8. AMP-activated protein kinase suppresses LXR-dependent sterol regulatory element-binding protein-1c transcription in rat hepatoma McA-RH7777 cells.
Yang J; Craddock L; Hong S; Liu ZM
J Cell Biochem; 2009 Feb; 106(3):414-26. PubMed ID: 19125418
[TBL] [Abstract][Full Text] [Related]
9. Sterol-responsive element-binding protein (SREBP) 2 down-regulates ATP-binding cassette transporter A1 in vascular endothelial cells: a novel role of SREBP in regulating cholesterol metabolism.
Zeng L; Liao H; Liu Y; Lee TS; Zhu M; Wang X; Stemerman MB; Zhu Y; Shyy JY
J Biol Chem; 2004 Nov; 279(47):48801-7. PubMed ID: 15358760
[TBL] [Abstract][Full Text] [Related]
10. Effects of niacin and chromium on the expression of ATP-binding cassette transporter A1 and apolipoprotein A-1 genes in HepG2 cells.
Siripurkpong P; Na-Bangchang K
J Nutr Biochem; 2009 Apr; 20(4):261-8. PubMed ID: 18602814
[TBL] [Abstract][Full Text] [Related]
11. SREBP-2 positively regulates transcription of the cholesterol efflux gene, ABCA1, by generating oxysterol ligands for LXR.
Wong J; Quinn CM; Brown AJ
Biochem J; 2006 Dec; 400(3):485-91. PubMed ID: 16901265
[TBL] [Abstract][Full Text] [Related]
12. Regulatory effects of synthetic liver X receptor- and peroxisome-proliferator activated receptor agonists on sterol transport pathways in polarized cerebrovascular endothelial cells.
Panzenboeck U; Kratzer I; Sovic A; Wintersperger A; Bernhart E; Hammer A; Malle E; Sattler W
Int J Biochem Cell Biol; 2006; 38(8):1314-29. PubMed ID: 16530456
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of liver x receptor/retinoid X receptor-mediated transcription contributes to the proatherogenic effects of arsenic in macrophages in vitro.
Padovani AM; Molina MF; Mann KK
Arterioscler Thromb Vasc Biol; 2010 Jun; 30(6):1228-36. PubMed ID: 20339114
[TBL] [Abstract][Full Text] [Related]
14. Anti-hyperlipidemic properties of CM108 (a flavone derivative) in vitro and in vivo.
Guo L; Hu WR; Lian JH; Ji W; Deng T; Qian M; Gong BQ
Eur J Pharmacol; 2006 Dec; 551(1-3):80-6. PubMed ID: 17026988
[TBL] [Abstract][Full Text] [Related]
15. Atorvastatin inhibits ABCA1 expression and cholesterol efflux in THP-1 macrophages by an LXR-dependent pathway.
Qiu G; Hill JS
J Cardiovasc Pharmacol; 2008 Apr; 51(4):388-95. PubMed ID: 18427282
[TBL] [Abstract][Full Text] [Related]
16. Regulation of macrophage cholesterol efflux through hydroxymethylglutaryl-CoA reductase inhibition: a role for RhoA in ABCA1-mediated cholesterol efflux.
Argmann CA; Edwards JY; Sawyez CG; O'Neil CH; Hegele RA; Pickering JG; Huff MW
J Biol Chem; 2005 Jun; 280(23):22212-21. PubMed ID: 15817453
[TBL] [Abstract][Full Text] [Related]
17. HMG-CoA reductase inhibitors (statins) activate expression of PPARalpha/PPARgamma and ABCA1 in cultured gallbladder epithelial cells.
Lee J; Hong EM; Koh DH; Choi MH; Jang HJ; Kae SH; Choi HS
Dig Dis Sci; 2010 Feb; 55(2):292-9. PubMed ID: 19225884
[TBL] [Abstract][Full Text] [Related]
18. Effect of pitavastatin on apolipoprotein A-I production in HepG2 cell.
Maejima T; Yamazaki H; Aoki T; Tamaki T; Sato F; Kitahara M; Saito Y
Biochem Biophys Res Commun; 2004 Nov; 324(2):835-9. PubMed ID: 15474503
[TBL] [Abstract][Full Text] [Related]
19. Pitavastatin increases ABCA1-mediated lipid efflux from Fu5AH rat hepatoma cells.
Zanotti I; Favari E; Sposito AC; Rothblat GH; Bernini F
Biochem Biophys Res Commun; 2004 Aug; 321(3):670-4. PubMed ID: 15358158
[TBL] [Abstract][Full Text] [Related]
20. Liver X receptor (LXR)-beta regulation in LXRalpha-deficient mice: implications for therapeutic targeting.
Quinet EM; Savio DA; Halpern AR; Chen L; Schuster GU; Gustafsson JA; Basso MD; Nambi P
Mol Pharmacol; 2006 Oct; 70(4):1340-9. PubMed ID: 16825483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
